It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
FNA’s FA Score shows that 0 FA rating(s) are green whileMDRSF’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
FNA’s TA Score shows that 5 TA indicator(s) are bullish.
FNA (@Medical Specialties) experienced а +40.00% price change this week, while MDRSF (@Medical Specialties) price change was 0.00% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.
FNA is expected to report earnings on Feb 27, 2025.
Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
FNA | MDRSF | FNA / MDRSF | |
Capitalization | 998M | 1.15B | 87% |
EBITDA | -26.92M | 11.7M | -230% |
Gain YTD | -19.469 | -14.469 | 135% |
P/E Ratio | 370.37 | N/A | - |
Revenue | 216M | 183M | 118% |
Total Cash | 75.6M | 20.6M | 367% |
Total Debt | 110M | 27.5M | 400% |
FNA | |
---|---|
RSI ODDS (%) | 3 days ago80% |
Stochastic ODDS (%) | 3 days ago88% |
Momentum ODDS (%) | 3 days ago73% |
MACD ODDS (%) | 3 days ago70% |
TrendWeek ODDS (%) | 3 days ago75% |
TrendMonth ODDS (%) | 3 days ago78% |
Advances ODDS (%) | 7 days ago75% |
Declines ODDS (%) | 25 days ago81% |
BollingerBands ODDS (%) | 3 days ago90% |
Aroon ODDS (%) | 3 days ago83% |
A.I.dvisor tells us that MDRSF and NHNKF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MDRSF and NHNKF's prices will move in lockstep.
Ticker / NAME | Correlation To MDRSF | 1D Price Change % | ||
---|---|---|---|---|
MDRSF | 100% | N/A | ||
NHNKF - MDRSF | 28% Poorly correlated | N/A | ||
FNA - MDRSF | 24% Poorly correlated | +3.20% | ||
OSUR - MDRSF | 24% Poorly correlated | -3.51% | ||
MHUA - MDRSF | 21% Poorly correlated | -5.39% | ||
ESMC - MDRSF | 21% Poorly correlated | N/A | ||
More |